Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.3 EUR | +1.47% |
|
-8.46% | +73.05% |
05/04 | Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications | MT |
28/03 | Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 51.33M 55.16M 4.6B | Sales 2025 * | 58.9M 63.29M 5.27B | Capitalization | 68.14M 73.22M 6.1B |
---|---|---|---|---|---|
Net income 2024 * | 1M 1.07M 89.55M | Net income 2025 * | 3M 3.22M 269M | EV / Sales 2024 * | 1.12 x |
Net cash position 2024 * | 10.53M 11.32M 943M | Net cash position 2025 * | 10.63M 11.43M 952M | EV / Sales 2025 * | 0.98 x |
P/E ratio 2024 * |
52.2
x | P/E ratio 2025 * |
18.5
x | Employees | 177 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98% |
Latest transcript on Apontis Pharma AG
1 day | +1.47% | ||
1 week | -8.46% | ||
Current month | -3.52% | ||
1 month | -11.42% | ||
3 months | +36.54% | ||
6 months | +77.92% | ||
Current year | +73.05% |
![Extreme 8.16](/images/extremecours_fleche.png)
![Extreme 8](/images/extremecours_fleche.png)
![Extreme 4.12](/images/extremecours_fleche.png)
![Extreme 3.03](/images/extremecours_fleche.png)
![Extreme 3.03](/images/extremecours_fleche.png)
![Extreme 3.03](/images/extremecours_fleche.png)
![Extreme 3.03](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | - | |
Director of Finance/CFO | - | 01/22/01 | |
Olaf Randerath
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Edin Hadzic
BRD | Director/Board Member | 53 | 01/21/01 |
Olaf Elbracht
BRD | Director/Board Member | 59 | 01/21/01 |
Chairman | 51 | 01/21/01 |
Date | Price | Change | Volume |
---|---|---|---|
18/24/18 | 8.22 | +0.49% | 459 |
17/24/17 | 8.18 | -0.24% | 954 |
14/24/14 | 8.2 | -3.30% | 5,355 |
13/24/13 | 8.48 | -0.70% | 2,917 |
12/24/12 | 8.54 | -4.90% | 28,631 |
Delayed Quote Xetra, June 18, 2024 at 07:12 pm IST
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+73.05% | 73.06M | |
+52.57% | 797B | |
+40.52% | 628B | |
-7.00% | 351B | |
+17.15% | 323B | |
+10.83% | 300B | |
+17.11% | 244B | |
+0.90% | 223B | |
+5.03% | 163B | |
-5.54% | 153B |
- Stock Market
- Equities
- APPH Stock